Flow cytometric analysis of Hep G2 cell cycle phases 48h-post compound HB5 treatment. Representative histograms showing the distribution of cell cycle phases of control and HB5-treated cells. Hep G2 hepatocyte carcinoma cells were treated with 2.87 µM (IC50 value) of compound HB5 for 48 h.

 
 
  Part of: Alsaad H, Kubba A, Tahtamouni LH, Hamzah AH (2022) Synthesis, docking study, and structure activity relationship of novel anti-tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic acid) moiety. Pharmacia 69(2): 415-428. https://doi.org/10.3897/pharmacia.69.e83158